$ACST why do you guys think our endpoint is 20% reduction? Been reading a lot about how AMRN’s MARINE trial did 33%. Wouldn’t we need to surpass 33% for this to be seen as better. Curious why they set the endpoint at 20%. I know secondary endpoints are key too. Would love your guys thoughts
  • 8